K
Kenneth A. Schneider
Researcher at National Institutes of Health
Publications - 13
Citations - 1231
Kenneth A. Schneider is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 7, co-authored 13 publications receiving 1222 citations.
Papers
More filters
Journal ArticleDOI
Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
Neil B. Shulman,Charles E. Ford,W D Hall,M D Blaufox,D Simon,Herbert G. Langford,Kenneth A. Schneider +6 more
TL;DR: The slightly lower rate of development of hypercreatininemia and the higher rate of improvement in stepped-care compared with referred-care participants is consistent with the belief that aggressive treatment of hypertension may reduce renal damage and the associated increased risk of death.
Journal ArticleDOI
Relation of Serum Vitamins a and E and Carotenoids to the Risk of Cancer
Walter C. Willett,B. F. Polk,B. A. Underwood,Meir J. Stampfer,Sara L. Pressel,Bernard Rosner,James Taylor,Kenneth A. Schneider,Curtis G. Hames +8 more
TL;DR: Measurements from the Hypertension Detection and Follow-up Program in 1973 do not support hypotheses relating intake or serum levels of antioxidant vitamins to a reduced cancer risk.
Journal ArticleDOI
Persistence of Reduction in Blood Pressure and Mortality of Participants in the Hypertension Detection and Follow-up Program
Neil Shulman,Elbert Tuttle,George Entwisle,Aristide Apostolides,Albert Oberman,Harold W. Schnaper,Edward H. Kass,James O. Taylor,B. Frank Polk,Jeremiah Stamler,Rose Stamler,Flora C. Gosch,Nemat O. Borhani,Beth Newman,Linda C. Harlan,Marshall Lee,Jack W. Jones,Sandra A. Daugherty,H. A. Tyroler,Curtis G. Hames,Siegfried Heyden,Lawrence M. Slotkoff,Socrates Fotiu,Herbert G. Langford,John Abernathy,Myra Tyler,Morton H. Maxwell,Andrew Lewin,Roger Detels,Reuben Berman,Ronald J. Prineas,Richard S. Crow,M. Donald Blaufox,Sylvia Wassertheil-Smoller,C. Hilmon Castle,Josephine Kasteller,C. Morton Hawkins,Charles E. Ford,Barry R. Davis,Agostino Molteni,Kenneth A. Schneider,Edward J. Fitzsimmons,Gerald H. Payne,Thomas P. Blaszkowski,William J. Zukel,Alvin P. Shapiro,Glenn E. Bartsch,Kenneth G. Berge,Edward S. Cooper,Edward D. Frohlich,Richard H. Gadsden,David L. Sackett,Joseph A. Wilber,W. McFate Smith,Walter M. Kirkendall,Curtis L. Meinert,Louis S. Monk,Richard D. Remington,Max Halperin +58 more
TL;DR: The absolute mortality advantage found at 6.7 years persisted and increased throughout the posttrial period of follow-up despite discontinuation of the formal SC therapy program, postulated that regression of hypertensive end-organ changes brought about by the more effective SC treatment caused this favorable outcome.
Journal ArticleDOI
The relationship of weight change to changes in blood pressure, serum uric acid, cholesterol and glucose in the treatment of hypertension.
Siegfried Heyden,Nemat O. Borhani,H. A. Tyroler,Kenneth A. Schneider,Herbert G. Langford,Curtis G. Hames,Richard Hutchinson,Albert Oberman +7 more
TL;DR: The potential importance of weight loss in enhancing effectiveness of antihypertensive drug treatment and attenuating increases in glucose, uric acid, and cholesterol associated with diuretic treatment of hypertension are suggested.
Journal ArticleDOI
Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program.
TL;DR: The Hypertension Detection and Follow-up Program data confirm the relative safety of antihypertensive therapy and confirm the beneficial effects of such therapy.